Andrade Robert 4
4 · FENNEC PHARMACEUTICALS INC. · Filed May 23, 2025
Insider Transaction Report
Form 4
Andrade Robert
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Common shares
2025-05-22$5.10/sh+8,220$41,922→ 158,520 total - Exercise/Conversion
Stock Options
2025-05-22$5.10/sh−8,220$41,922→ 850,751 totalExercise: $5.10From: 2017-06-27Exp: 2027-06-27→ Options (8,220 underlying)
Footnotes (1)
- [F1]Shares acquired through the exercise of an option contract with strike price of $5.10 and an expiration date of June 27, 2027.